Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Lolkema, M.P.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(8)
+
-
Availability
Open access
(5)
+
-
Metadata Only
(3)
+
-
Creation Date
2022
(3)
+
-
2021
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(7)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(7)
+
-
Topic
CD40
(2)
+
-
Dendritic Cell
(2)
+
-
Immunotherapy
(2)
+
-
Pancreatic cancer
(2)
+
-
Vaccines
(2)
+
-
Author
Lolkema, M.P.
(8)
+
-
Gelderblom, H.
(5)
+
-
Cuppen, E.
(3)
+
-
Eijck, C.H.J. van
(3)
+
-
Groot, J.W.B. de
(3)
+
-
Haar, J. van de
(3)
+
-
Hoes, L.R.
(3)
+
-
Homs, M.Y.V.
(3)
+
-
Roepman, P.
(3)
+
-
Smit, E.F.
(3)
+
-
Verheul, H.M.W.
(3)
+
-
Voest, E.E.
(3)
+
-
Aerts, J.G.J.V.
(2)
+
-
Beerepoot, L.V.
(2)
+
-
Burg, S.H. van der
(2)
+
-
Erdkamp, F.
(2)
+
-
Gort, E.H.
(2)
+
-
Graaf, W.T.A. van der
(2)
+
-
Groot, D.J. de
(2)
+
-
Hendriks, M.P.
(2)
+
-
Henegouwen, J.M.V.
(2)
+
-
Herpen, C.M.L. van
(2)
+
-
Hess, D.
(2)
+
-
Hoeben, A.
(2)
+
-
Huitema, A.D.R.
(2)
+
-
Hussain, S.A.
(2)
+
-
Jansen, A.M.L.
(2)
+
-
Kerver, E.D.
(2)
+
-
Labots, M.
(2)
+
-
Land, F.R. van 't
(2)
+
-
Lau, S.P.
(2)
+
-
Leng, W.J. de
(2)
+
-
Morreau, H.
(2)
+
-
Mu, S.
(2)
+
-
Noort, V. van der
(2)
+
-
Sharma, S.
(2)
+
-
Velden, D.L. van der
(2)
+
-
Waldron, E.
(2)
+
-
Werkhoven, E. van
(2)
+
-
Wijngaart, H. van der
(2)
+
-
Witteveen, P.O.
(2)
+
-
Zeverijn, L.J.
(2)
+
-
Show more
Language
en
(8)
+
-
Search results
(1 - 8 of 8)
show grid
show list
save search
Patients with rare cancers in the drug rediscovery protocol (DRUP) benefit from genomics-guided treatment
Safety and tumour-specific immunological responses of combined dendritic cell vaccination and anti-CD40 agonistic antibody treatment for patients with metastatic pancreatic cancer
Safety and tumour-specific immunological responses of combined dendritic cell vaccination and anti-CD40 agonistic antibody treatment for patients with metastatic pancreatic cancer
Patients with rare cancers in the Drug Rediscovery Protocol (DRUP) benefit from genomics-guided treatment
Limited evolution of the actionable metastatic cancer genome under therapeutic pressure
Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX
A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and varying degrees of renal function
Oral panobinostat in patients with advanced tumors and impaired renal function: Relationship between pharmacokinetics and key safety parameters